TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Previous meta-analyses conducted between TM6SF2 rs58542926 and NAFLD mainly focused on the sole association between rs58542926 and susceptibility to NAFLD or aminotransferase or serum lipid levels or the progression of NAFLD or some phenotypes (12, 70, 72–74).